Bruker AXS Launches Its Complete New X8 Product Line for Life Science Applications at IUCr-Conference in Geneva, Switzerland.Business Editors & Health/Medical Writers BIOWIRE2K MADISON, Wis.--(BW HealthWire)--Aug. 7, 2002 Bruker AXS Bruker AXS is an international instrument manufacturer and supplier. The company is part of Bruker and specialized on Analytical X-Ray Systems. The main parts are the X-Ray diffraction and the X-Ray spectrometry. Inc. (Nasdaq:BAXS), a leading global provider of advanced X-ray solutions for the life and advanced materials Advanced Materials is a leading peer-reviewed materials science journal published every two weeks. Advanced Materials includes Communications, Reviews, and Feature Articles from the cutting edge of materials science, including topics in chemistry, physics, sciences, today announced that it has launched an entire new product line for life science applications, named the X8 series. "The new products are a result of the joint R&D and marketing activities Bruker AXS has undertaken after the acquisition of Nonius in April 2001," commented Lieuwe Boskma, VP Crystallography Solutions. "They combine the best technologies of Bruker AXS and Nonius, and are geared towards providing complete solutions, especially for the High-Throughput Structural Proteomics market. It is our goal to become a leading supplier of both screening and research instrumentation. The new products are using latest technologies and offer a high degree of automation. Release of this X8 series is a first major step onto this path." "I am really pleased to see that within one year after the acquisition of Nonius our combined efforts in R&D and marketing have resulted in an exciting line of new products addressing the needs of our target markets in the X-ray Crystallography X-ray crystallography, the study of crystal structures through X-ray diffraction techniques. When an X-ray beam bombards a crystalline lattice in a given orientation, the beam is scattered in a definite manner characterized by the atomic structure of the lattice. ," added Martin Haase, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "These new product introductions will further fuel our growth in this attractive market segment. We will continue with our current pace of innovation following our complete solutions philosophy and provide our customers with easy to use and reliable products for their demanding applications." X8PROTEUM FOR HIGH THROUGHPUT STRUCTURAL PROTEOMICS AND SCREENING The X8PROTEUM(TM) is introduced as the top-of-the-line instrument for structural bio-molecular research in the pharmaceutical and biotechnology industries, and for fundamental structural biology Structural biology is a branch of molecular biology concerned with the study of the architecture and shape of biological macromolecules—proteins and nucleic acids in particular—and what causes them to have the structures they have. research. It combines the most sensitive PROTEUM CCD CCD in full charge-coupled device Semiconductor device in which the individual semiconductor components are connected so that the electrical charge at the output of one device provides the input to the next device. detector with the extremely versatile kappa Goniometer goniometer /go·ni·om·e·ter/ (go?ne-om´e-ter) 1. an instrument for measuring angles. 2. a plank that can be tilted at one end to any height, used in testing for labyrinthine disease. and therefore allows for efficient sample screening and collecting highly redundant data-sets, enhancing in-house laboratory capabilities and reducing the need for data collection at synchrotron synchrotron: see particle accelerator. synchrotron Cyclic particle accelerator in which the particle is confined to its orbit by a magnetic field. The strength of the magnetic field increases as the particle's momentum increases. sites. X8APEX FOR SMALL MOLECULE STRUCTURE RESEARCH The X8APEX(TM) is designed for structure-based drug design in the pharmaceutical industry and for fundamental research in chemistry, mineralogy mineralogy Scientific study of minerals, including their physical properties, chemical composition, internal crystal structure, occurrence and distribution in nature, and origins or conditions of formation. and physics, integrating the most sensitive APEX CCD detector for molybdenum molybdenum (məlĭb`dənəm) [Gr.,=leadlike], metallic chemical element; symbol Mo; at. no. 42; at. wt. 95.94; m.p. about 2,617°C;; b.p. about 4,612°C;; sp. gr. 10.22 at 20°C;; valence +2, +3, +4, +5, or +6. wavelengths with the highly appreciated Kappa Goniometer. This provides highest speed and throughput while also offering a high degree of flexibility to address the various demands of our customers in industry and academia. BruNo - FIRST EASY-TO-USE CRYOGENIC SAMPLE ROBOT Sample changing of single crystals, manual until very recently, has been automated by introduction of the BruNo robotics system that takes the cryo-cooled protein sample from a liquid-nitrogen storage dewar and mounts it on the goniometer, then retrieves it for further experiments. For this procedure, patented Kryo-Vials(TM) are used to transport the crystals to and from the storage dewar at liquid-nitrogen temperatures, yet do away with the liquid itself, assuring a straightforward and much safer sample handling. Compared to the time-consuming manual sample mounting, BruNo will speed up preparation by an order of magnitude A change in quantity or volume as measured by the decimal point. For example, from tens to hundreds is one order of magnitude. Tens to thousands is two orders of magnitude; tens to millions is three orders of magnitude, etc. . PROTEUM & APEX- NEXT GENERATION OF CRYSTALLOGRAPHY SOFTWARE FOR DATA ACQUISITION AND STRUCTURE ANALYSIS A new generation of highly intuitive software is simultaneously launched, running on either LINUX or WINDOWS. It will enable the novice to control the system to full extent, yet allow experts to take full advantage of all features, including comprehensive support of twinned samples, enhanced 2D & 3D visualisation, precession photographs, XML XML in full Extensible Markup Language. Markup language developed to be a simplified and more structural version of SGML. It incorporates features of HTML (e.g., hypertext linking), but is designed to overcome some of HTML's limitations. and LIMS LIMS Laboratory Information Management System LIMS Library Information Management System LIMS Limb Infrared Monitor of the Stratosphere LIMS Land Information Management System (Canada) LIMS Logistics Information Management System compatibility for trouble-free bio-informatics, FFT (Fast Fourier Transform) A class of algorithms used in digital signal processing that break down complex signals into elementary components. FFT - Fast Fourier Transform indexing from single exposures and an automatic strategy organizer. About Bruker AXS Bruker AXS is a leading developer and provider of life science and advanced materials research tools based on X-ray technology. The company develops, manufactures and markets worldwide advanced X-ray solutions for the three-dimensional structure determination of biological and chemical compounds, as well as for advanced materials research and analysis. Its diverse customer base includes pharmaceutical and biotechnology companies, advanced materials, semiconductor, synthetic polymer, and basic materials companies, as well as university and government research customers. Applications include x-ray crystallography for structural proteomics, and automated systems for combinatorial materials sciences. Bruker AXS has the most diverse set of x-ray technology platforms for molecular and materials analysis. Safe-Harbor Statement Statements in this press release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements involve a high degree of risk and uncertainty that exist in the Company's operations and business environment. Such statements are predictions only and actual events or results may differ materially from those projected in such forward-looking statements. Factors that could affect actual events or results include risks associated with performance under the Company's agreements with third parties, research and development progress, competitive products and the strength of the Company's patent portfolio. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion